Drug GMP Report
October 2012
FDA Documents, Statements Prioritize the ‘P’ in CAPA: Expert
An effective corrective and preventive action (CAPA) program will prioritize prevention and continuity in process improvement — primarily by linking to manufacturing systems beyond those concerned with deviation management and failure investigations, compliance experts say.
This article is viewable by subscribers only. To view this article, please select an option below.
|